Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Indian Journal of Pediatrics
Published in: Indian Journal of Pediatrics 1/2017

01-01-2017 | Review Article

Pediatric Hematopoietic Stem Cell Transplantation in India: Status, Challenges and the Way Forward

Based on Dr. K. C. Chaudhuri Oration 2016

Authors: Vineet Govinda Gupta, Sameer Bakhshi

Published in: Indian Journal of Pediatrics | Issue 1/2017

Login to get access

Abstract

Hematopoietic stem cell transplantation (HSCT) refers to therapies that aim to eliminate a patient’s hematopoietic and immune system and replace it with his own (autologous) or someone else’s (allogenic) system. The applications of this therapy are vast and growing, and include several malignant and benign diseases incurable by any other existing modalities. Pediatric patients constitute a minority of HSCT recipients with unique concerns. Despite substantial progress in the last two decades, limitations due to financial, infrastructural, manpower and research constraints act as barriers to fulfilling the large need for pediatric HSCT services in our country. Limited availability of unrelated donors and cord blood units is another constraint. Here in this oration, we discuss the current issues pertaining to pediatric HSCT in India and describe our experience with the same.
Literature
1.
Thomas ED, Blume KG. Historical markers in the development of allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 1999;5:341–6.CrossRef
2.
Barnes DW, Corp MJ, Loutit JF, Neal FE. Treatment of murine leukaemia with X rays and homologous bone marrow; preliminary communication. Br Med J. 1956;2:626–7.CrossRefPubMedPubMedCentral
3.
Passweg JR, Baldomero H, Peters C, et al. Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation. Bone Marrow Transplant. 2014;49:744–50.CrossRefPubMedPubMedCentral
4.
Lucarelli G, Galimberti M, Polchi P, et al. Marrow transplantation in patients with thalassemia responsive to iron chelation therapy. N Engl J Med. 1993;329:840–4.CrossRefPubMed
5.
O’Brien SG, Guilhot F, Larson RA, et al. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med. 2003;348:994–1004.CrossRefPubMed
6.
Cauvin HE. Cancer researcher in South Africa who falsified data is fired. N Y Times Web. 2000 Mar;11:A16.
7.
Weiss RB, Gill GG, Hudis CA. An on-site audit of the south African trial of high-dose chemotherapy for metastatic breast cancer and associated publications. J Clin Oncol. 2001;19:2771–7.PubMed
8.
9.
Chandy M, Srivastava A, Dennison D, Mathews V, George B. Allogeneic bone marrow transplantation in the developing world: experience from a center in India. Bone Marrow Transplant. 2001;27:785–90.CrossRefPubMed
10.
George B, Mathews V, Srivastava A, Chandy M. Infections among allogeneic bone marrow transplant recipients in India. Bone Marrow Transplant. 2004;33:311–5.CrossRefPubMed
11.
Chandy M. Innovative supportive care practices for stem cell transplantation in India. Biol Blood Marrow Transplant. 2009;15:95–8.CrossRefPubMed
12.
George B, Mathews V, Viswabandya A, Lakshmi KM, Srivastava A, Chandy M. Allogeneic hematopoietic stem cell transplantation is superior to immunosuppressive therapy in Indian children with aplastic anemia--a single-center analysis of 100 patients. Pediatr Hematol Oncol. 2010;27:122–31.CrossRefPubMed
13.
Yadav SP, Sachdeva A. Pediatric allogeneic stem cell transplantation: experience from the developing world. Pediatr Hematol Oncol. 2014;31:205–6.CrossRefPubMed
14.
George B, Mathews V, Lakshmi KM, et al. The use of a fludarabine-based conditioning regimen in patients with severe aplastic anemia--a retrospective analysis from three Indian centers. Clin Transpl. 2013;27:923–9.CrossRef
15.
Shah SA, Shah KM, Patel KA, et al. Unrelated umbilical cord blood transplant for children with β-thalassemia major. Indian J Hematol Blood Transfus. 2015;31:9–13.CrossRefPubMed
16.
Shah CA, Karanwal A, Desai M, Pandya M, Shah R, Shah R. Hematopoietic stem-cell transplantation in the developing world: experience from a center in western India. J Oncol. 2015;2015:710543.CrossRefPubMedPubMedCentral
17.
18.
Gratwohl A, Passweg J, Baldomero H, Horisberger B, Urbano-Ispizua A; Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT). Economics, health care systems and utilization of haematopoietic stem cell transplants in Europe. Br J Haematol. 2002;117:451–68.
19.
Mitchell JM, Meehan KR, Kong J, Schulman KA. Access to bone marrow transplantation for leukemia and lymphoma: the role of sociodemographic factors. J Clin Oncol. 1997;15:2644–51.PubMed
20.
21.
22.
23.
Shukla R. How India earns, spends and saves: unmasking the real India. Sage India; 2010. p. 232.
24.
Kumar R, Naithani R, Mishra P, et al. Allogeneic hematopoietic SCT performed in non-HEPA filter rooms: initial experience from a single center in India. Bone Marrow Transplant. 2009;43:115–9.CrossRefPubMed
25.
Kayal S, Sharma A, Iqbal S, Tejomurtula T, Cyriac SL, Raina V. High-dose chemotherapy and autologous stem cell transplantation in multiple myeloma: a single institution experience at all India Institute of Medical Sciences, New Delhi, using non-cryopreserved peripheral blood stem cells. Clin Lymphoma Myeloma Leuk. 2014;14:140–7.CrossRefPubMed
26.
López-Otero A, Ruiz-Delgado GJ, Ruiz-Argüelles GJ. A simplified method for stem cell autografting in multiple myeloma: a single institution experience. Bone Marrow Transplant. 2009;44:715–9.CrossRefPubMed
27.
Arora RS, Bakhshi S. Indian pediatric oncology group (InPOG) – collaborative research in India comes of age. Pediatr Hematol Oncol J. 2016;1:13–7.CrossRef
28.
Kekre N, Antin JH. Hematopoietic stem cell transplantation donor sources in the twenty-first century: choosing the ideal donor when a perfect match does not exist. Blood. 2014;124:334–43.CrossRefPubMed
29.
Switzer GE, Bruce JG, Myaskovsky L, et al. Race and ethnicity in decisions about unrelated hematopoietic stem cell donation. Blood. 2013;121:1469–76.CrossRefPubMedPubMedCentral
30.
31.
32.
Kanga U, Panigrahi A, Kumar S, Mehra NK. Asian Indian donor marrow registry: all India Institute of Medical Sciences experience. Transplant Proc. 2007;39:719–20.CrossRefPubMed
33.
34.
Maiers M, Halagan M, Joshi S, et al. HLA match likelihoods for Indian patients seeking unrelated donor transplantation grafts: a population-based study. Lancet Haematol. 2014;1:e57–63.CrossRefPubMed
35.
Bahl A, Bakhshi S. Umbilical cord blood transplant for malignancies: a hope or hype. Indian J Pediatr. 2013;80:675–80.CrossRefPubMed
36.
37.
38.
Thornley I, Eapen M, Sung L, Lee SJ, Davies SM, Joffe S. Private cord blood banking: experiences and views of pediatric hematopoietic cell transplantation physicians. Pediatrics. 2009;123:1011–7.CrossRefPubMedPubMedCentral
39.
Armson BA. Maternal/fetal medicine committee, Society of Obstetricians and Gynaecologists of Canada. Umbilical cord blood banking: implications for perinatal care providers. J Obstet Gynaecol Can. 2005;27:263–90.CrossRefPubMed
40.
American Academy of Pediatrics Section on Hematology/Oncology, American Academy of Pediatrics Section on Allergy/Immunology, Lubin BH, Shearer WT. Cord blood banking for potential future transplantation. Pediatrics. 2007;119:165–70.
41.
Tichelli A, Rovó A. Fertility issues following hematopoietic stem cell transplantation. Expert Rev Hematol. 2013;6:375–88.CrossRefPubMed
42.
Porada CD, Atala AJ, Almeida-Porada G. The hematopoietic system in the context of regenerative medicine. Methods San Diego Calif. 2016;99:44–61.CrossRef
43.
Margini C, Vukotic R, Brodosi L, Bernardi M, Andreone P. Bone marrow derived stem cells for the treatment of end-stage liver disease. World J Gastroenterol. 2014;20:9098–105.PubMedPubMedCentral
44.
Currò D, Mancardi G. Autologous hematopoietic stem cell transplantation in multiple sclerosis: 20 years of experience. Neurol Sci. 2016;37:857–65.CrossRefPubMed
45.
van Laar JM, Sullivan K. Stem cell transplantation in systemic sclerosis. Curr Opin Rheumatol. 2013;25:719–25.CrossRefPubMed
46.
Rebeiro P, Moore J. The role of autologous haemopoietic stem cell transplantation in the treatment of autoimmune disorders. Intern Med J. 2016;46:17–28.CrossRefPubMed
Metadata
Title
Pediatric Hematopoietic Stem Cell Transplantation in India: Status, Challenges and the Way Forward
Based on Dr. K. C. Chaudhuri Oration 2016
Authors
Vineet Govinda Gupta
Sameer Bakhshi
Publication date
01-01-2017
Publisher
Springer India
Published in
Indian Journal of Pediatrics / Issue 1/2017
Print ISSN: 0019-5456
Electronic ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-016-2253-5

Other articles of this Issue 1/2017

Indian Journal of Pediatrics 1/2017 Go to the issue

Review Article

Early Identification of Young Children with Autism Spectrum Disorder

Review Article

Evidence-Based Social Communication Interventions for Children with Autism Spectrum Disorder

Editorial

Editorial: Autism – Hype and Hope

Original Article

Performance of Two Different Pulse Oximeters in Neonatal Transition

Picture of the Month

Brittle Hair, Photosensitivity, Brain Hypomyelination and Immunodeficiency: Clues to Trichothiodystrophy

Scientific Letter

Genetically Confirmed Neonatal Diabetes: A Single Centre Experience